Avg closing price
Price range

2 Seth Klarman Nuvation Bio- Class A Trades

Seth Klarman's position in Nuvation Bio- Class A is currently worth $43.8 Million. That's 0.57% of their equity portfolio (25th largest holding). The investor owns 4.76% of the outstanding Nuvation Bio- Class A stock. The investor's estimated purchase price is $109 Million, resulting in a loss of 60%.

Avg closing price
Price range
Increased shares by 21.1% (+1.82 Million shares) Q1 2022
Avg closing price $5.62
Price range $4.60 - $8.83
New holding (+8.62 Million shares) Q1 2021
Avg closing price $11.47
Price range $9.00 - $14.57

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!